The efficacy of EMDR in youngsters with autism

Completed

Conditions: Autism
Autism spectrum disorder
10010118

Registration Number: NL-OMON45375

Lead Sponsor: Karakter, expertisecentrum voor kinder- en jeugdpsychiatrie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 20

Inclusion Criteria

• Diagnosed with ASD (with or without comorbid psychiatric disorders, except PTSD and
anxiety disorders)
• Full-scale IQ of 80 or more
• 12-21 years of age
• Able to understand and speak Dutch

Exclusion Criteria

• Youngsters exposed to other treatments than medication on a stable dosage
• Presence of PTSD or other comorbid psychiatric disorders that require immediate treatment

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main endpoint of the study are autism symptoms, which will be assessed<br /><br>using the Social Responsiveness Scale (SRS-A) and the Autism Diagnostic<br /><br>Observation Schedule (ADOS 2). The SRS-A will be administered prior, during and<br /><br>after treatment. The ADOS 2 will be administered prior to treatment and after<br /><br>treatment completion. In addition, we will also administer the Trauma Symptom<br /><br>Investigation Form in Autism Spectrum Disorders (TIF-ASD) questionnaire prior<br /><br>to, during, and after treatment. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To answer more fundamental questions concerning the working mechanism of EMDR<br /><br>in ASD, other secondary outcome measures (i.e. Clinical Global Impression<br /><br>Scales (CGI), Perceived Stress Scale-10 (PSS-10) en de Alloway Working Memory<br /><br>Assessment (AWMA-2)) will be included. </p><br>